July 21, 2025

Remdesivir Not Tied to Cardiac Risk

In a meta-analysis of 4566 patients with COVID-19, researchers found no statistically significant increase in cardiac adverse events associated with remdesivir treatment and concluded that the drug does not raise heart-related safety concerns.

Conexiant

July 18, 2025

Decade of Data Validates Life’s Simple 7

A decade-long review supports that higher Life’s Simple 7 cardiovascular health scores significantly reduce risks of chronic disease, mortality, and health care use.

Conexiant

July 17, 2025

Mount Sinai Study: Controlling Heart Rhythm Before m-TEER Improves Outcomes

Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for severe mitral regurgitation are more than twice as likely to die or be rehospitalized for heart failure, compared to patients without AF. These are the findings from a Mount Sinai Fuster Heart Hospital study that links the presence of AF at the time of the procedure to worse outcomes following the procedure.

Mount Sinai New York

July 17, 2025

Vapes Outperform Nicotine Replacement Therapy in Cessation Trial

Researchers found vaporized nicotine products more effective than nicotine replacement therapy for smoking cessation among socioeconomically disadvantaged adults.

Conexiant

July 16, 2025

Multidisciplinary Valve Expertise, Exceptional Outcomes Why Referring Physicians Trust Baptist Health for Heart Valve Disease Care

An estimated 2.5% of the U.S. population is affected by valvular heart disease, with prevalence increasing sharply with age. In fact, up to 13% of people over 75 have moderate or severe valve disease,

Baptist Health South Florida

July 10, 2025

HHS Scraps Preventive Care Panel Meeting

HHS unexpectedly canceled a meeting of the U.S. Preventive Services Task Force, prompting fears it may be dismantled following similar moves by Secretary Robert F. Kennedy Jr. at other federal health agencies.

Conexiant

July 10, 2025

No Heart Risk Found With Triptan Use

A large real-world study found no significant increase in short-term heart attack or stroke risk among migraine patients using triptans, including those with cardiovascular risk factors.

Conexiant

July 09, 2025

ESC: Vaccines May Prevent Major Heart Events

A new ESC clinical statement finds that common vaccines, including those for influenza and COVID-19, may lower cardiovascular risks such as heart attack, stroke, and heart failure, particularly in high-risk patients.

Conexiant

July 09, 2025

Better Cholesterol Treatment Could Prevent Thousands of Cardiovascular Events

Most adults with high LDL cholesterol are not receiving recommended treatments and are not fully following clinical guidelines.

Conexiant